 |
|
|
 |
|
|
|
Information Paris, May 18, 2004 Press Release Freeze-drying drugs with liquid nitrogen at leading Greek pharmaceutical company VIANEX S.A.
Installed by Air Liquide subsidiary Usifroid, this unit uses liquid nitrogen supplied by the Group to freeze-dry injectble sterile products. In the freeze-drying (also called lyophilization) process, the solvent, generally water, is frozen in two stages: sublimatino and low-pressure evaporation. this method which requirs highly specific production conditions yields excellent results, particularly in terms of conservation and stability of the products. The necessary huge quantities of liquid nitrogen will be monitored by a remote control installation called Teleflo, an innovative system developed by Air Liquide to free its customers from the concerns of managing their gas supply. Terms from Air Liquide's Greek subsidiary, Air Liquide Hellas, have commissioned the installation in line with the customer's expectatins. Commenting on the signature of this new contract, Jean-Pierre Duprieu, Senior Vice President and Member or Air Liquide Executive Committee, said: "We are very proud to have been selected by this leading pharmaceutical company to supply them with a simple, reliable solution. This agreement reflects the dynamism of our business in southern Europe, where we have forged a solid relationship based on our proximity with our industrial customers". Founded in 1909, Air Liquide Hellas is a subsidiary of Air Liquide (98.7% shareholder). It employs 205 people and achieved sales of € 34.5 million in 2003. ****************** Present in 65 countries, Air Liquide is the qorld leader in industrial and medical gases and related services. The Group offers innovative solutions based on constantly enhanced technologies. These solutions, which are in line with Air Liquide's commitment to sustainable development, help to protect life and enable our customers to manufacture meny indispensable everyday products. Founded in 1902, Air Liquide has more than 31,900 employees. The Group has successfully developed a long-term relationship with its shareholders built on confidence and transparency and guided by the principles of corporate governance. Sales in 2003 totaled 8,394 million euros, of which sales outside France accounted almost 80%. Ait Liquide is listed on the Euronext Paris stock exchange and is a component of the CAC 40 and EuroStoxx 50 indexes (ISIN code FR 0000120073). For further information, please contact:
www.airliquide.gr |
||||||||||||
 |
||||||||||||
